Citadel Advisors - ZOSANO PHARMA CORP ownership

ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 30 filers reported holding ZOSANO PHARMA CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ZOSANO PHARMA CORP
ValueSharesWeighting
Q1 2022$6,000
-94.3%
28,483
-80.5%
0.00%
Q3 2021$105,000
+176.3%
146,166
+263.9%
0.00%
Q2 2021$38,000
-80.9%
40,167
-75.0%
0.00%
Q1 2021$199,000
+665.4%
160,724
+247.5%
0.00%
Q1 2020$26,000
-51.9%
46,257
+249.7%
0.00%
Q3 2018$54,00013,2290.00%
Other shareholders
ZOSANO PHARMA CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 526,741$278,0000.47%
Aisling Capital Management LP 2,718,226$1,433,0000.25%
Sio Capital Management, LLC 427,542$225,0000.05%
Virtu Financial LLC 198,673$105,0000.01%
GSA CAPITAL PARTNERS LLP 121,978$64,0000.01%
Wealthcare Advisory Partners LLC 68,754$36,0000.00%
Highlander Capital Management, LLC 10,000$5,0000.00%
WINTON GROUP Ltd 66,873$35,0000.00%
Compagnie Lombard Odier SCmA 60,000$32,0000.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$527,0000.00%
View complete list of ZOSANO PHARMA CORP shareholders